Plexxikon is a company engaged in the discovery and development of novel, small molecule pharmaceuticals. It offers products for the treatment of diabetes, melanoma and colorectal cancer, and pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease.